Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1994-12-21
1999-02-16
Harrison, Robert H.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
514165, 514824, 549408, A61K 3107, A61K 31355, A61K 31605
Patent
active
058717668
ABSTRACT:
This invention is directed to a method for inhibiting the occurrence of a major vascular event in a subject whereby a subject is administered beta-carotene and/or vitamin E, either alone or in combination. Beta-carotene and/or vitamin E is administered such that the subject's risk of experiencing a major vascular event is thereby reduced. In another preferred embodiment, beta-carotene in combination with aspirin is particularly effective.
The invention further includes pharmaceutical compositions comprising beta-carotene in combination with vitamin E.
REFERENCES:
patent: 3853993 (1974-12-01), Gainer
patent: 4304784 (1981-12-01), Fujimura et al.
patent: 4491574 (1985-01-01), Seifter et al.
patent: 5057494 (1991-10-01), Sheffield
patent: 5153001 (1992-10-01), Ismail
patent: 5221668 (1993-06-01), Henningfield et al.
patent: 5278189 (1994-01-01), Rath et al.
patent: 5310554 (1994-05-01), Haigh
patent: 5326757 (1994-07-01), Demopolous
patent: 5328845 (1994-07-01), Finkelstein et al.
patent: 5346488 (1994-09-01), Prince et al.
patent: 5422247 (1995-06-01), Finklestein et al.
patent: 5589468 (1996-12-01), Lin et al.
patent: 5607839 (1997-03-01), Tsubokura et al.
patent: 5612485 (1997-03-01), Schlipalius
patent: 5773026 (1998-06-01), Schlipalius
Morel et al., "Low Density Lipoprotein Cytotoxicity Induced by Free Radical Peroxidation of Lipid", Journal of Lipid Research, vol. 24, pp. 1070-1076 (1983).
Drug Facts and Comparisons; 44 Edition, Lippincott, pp. 6-7, 13-14, 60,62, 997-998.
Goodman, DeWitt S. Vitamin A and Retinoids in Health and Disease. The New England Journal of Medicine. 310(16), Apr. 19, 1984. pp. 1023-1031.
Council on Scientific Affairs, Chicago. Vitamin Preparations as Dietary Supplements and as Therapeutic Agents. JAMA, 257(14), Apr. 10, 1987. pp. 1929-1936.
Beta-Carotene, Vitamin A and E may not Prevent Cancer or Cardiovascular Diseases. WHO Drug Information. 11(1), (1997). pp 10-11.
Belanger, C. et al., "Preliminary Report: Findings from the Aspirin Component of the Ongoing Physician's Health Study," New Engl. J. Med. 318(4):262-264 (1988).
English Language Abstract of Hungarian Patent No. 207 214 B, Derwent World Patents Index, WPI Accession No. 93-177727 (1993).
English language translation of European Patent Application 0 204 987 A1.
Fedan, J.S., "Anticoagulant, Antiplatelet, and Fibrinolytic (Thrombolytic) Drugs," In: Modern Pharmacology, 3rd ed., Craig, C.R. and Stitzel, R.E., eds., Little Brown and Company: Boston (May 1990), pp. 370-385.
Afonsky, S.I., "Biochemistry of Animals," Moscow, pp. 235-236 (1970).
Mashkovsky, M.D., "Medicinal Substances," Part 2, Medicina Publishers, Moscow, pp. 37-38, 40-41, 190-191 (1988).
Partial English translations of documents AT9, AR10, AS10 and AT10.
Supplementary Partial European Search Report for European Patent Application No. 91919463.9 (Jul. 14, 1993).
Gey, K.F., On the Antioxidant Hypothesis with Regard to Arteriosclerosis, Bibl. Nutr. Dieta 37:53-91 (1986).
Nicol, M., Vitamines and antioxydantes et beta-carotene: activites preventives en pathologie humaine, Med. et Nutr. (France) 26:35-37 (1990).
Gaziano, J.M. et al., Dietary Antioxidants and Cardiovascular Disease, Annals of the New York Academy of Sciences 669:249-259 (1992).
Manson, J.E. et al., A Prospective Study of Antioxidant Vitamins and Incidence of Coronary Heart Disease in Women, Circulation 84(Supplement II):II-546, Abstract No. 2168 (1991).
M.o slashed.gelvang, B., Can anti-oxidants be used to prevent ischemic vascular disorders?, Nordisk Medicin 107:53-56 (1992).
Morel, D.W. et al., Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid, Journal of Lipid Research 24:1070-1076 (1983).
van Hinsbergh, V.W.M. et al., Role of endothelial cells and their products in the modification of low-density lipoproteins, Biochimica et Biophysica Acta 878:49-64 (1986).
Leibovitz et al., Dietary Supplements of Vitamin E., .beta.-Carotene, Coenzyme Q.sub.10 and Selenium Protect Tissues Against Lipid Peroxidation in Rat Tissue Slices. J. Nutr. 120:97-104 (1990).
Parthasarathy et al., A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein, Proc. Natl. Acad. Sci. USA 86:1046-1050 (1989).
Steinberg et al., New England J. Medicine 320(14):915-924 (1989).
Smith et al., Atherosclerosis 75:105-109 (1989).
Carew et al., PNAS USA 84:7725-7729 (1987).
Gey et al., Am. J. Clin. Nutr. 45:1368-1377 (1987).
Kok et al., Am. J. Clin. Nutr. 45:462-468 (1987).
Hale et al., J. Am. Diet. Assn. 86(5):625-629 (1986).
Parthasarathy et al., J. Clin. Invest. 77:641-644 (1986).
Cathcart et al., J. Leukocyte Biol. 38:341-350 (1985).
Morel et al., Arteriosclerosis 4(4):357-364 (1984).
Burton et al., Science 224:569-573 (1984).
Kunio Yagi, Bioessays 1:58-60 (1984).
Hessler et al., Arteriosclerosis 3(3):215-222 (1983).
Fogelman et al., PNAS USA 77(4):2214-2218 (1980).
Gillilan et al., Am. Heart J. 93(4):444-449 (1977).
Knut Haeger, Am. J. Clin. Nutr. 27:1179-1181 (1974).
Anderson et al., Am. J. Clin. Nutr. 27:1174-1178 (1974).
Brigham and Women's Hospital
Harrison Robert H.
LandOfFree
Beta-carotene vitamin E therapy for inhibition of major vascular does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-carotene vitamin E therapy for inhibition of major vascular, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-carotene vitamin E therapy for inhibition of major vascular will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2059842